Mostrar el registro sencillo del ítem

dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.contributor.authorUrina-Jassir, Daniela
dc.contributor.authorUrina-Jassir, Manuel
dc.contributor.authorUrina-Triana, Miguel
dc.contributor.authorMantilla-Morrón, Mirary
dc.contributor.authorUrina-Triana, Manuel
dc.contributor.authorGaleano-Muñoz, Luisa
dc.date.accessioned2019-01-16T14:28:16Z
dc.date.available2019-01-16T14:28:16Z
dc.date.issued2018
dc.identifier.issn18564550
dc.identifier.urihttp://hdl.handle.net/20.500.12442/2446
dc.description.abstractIntroducción y Objetivos: El desarrollo del aumento de la grasa central abdominal, de la alteración del perfil lipídico y de la resistencia a la insulina encontrado en el síndrome metabólico están mayormente presentes en la menopausia. Conocer la prevalencia del SM en mujeres postmenopáusicas en Barranquilla, permitirá desarrollar estrategias futuras para disminuir su presencia y la de las enfermedades cardiovasculares. Material y Métodos: Estudio transversal, realizado en Barranquilla, Colombia entre octubre a noviembre 2016, en mujeres con edad laboral. El diagnóstico del SM se hizo con al menos tres de los cinco criterios propuestos por el consenso de la Federación Internacional de Diabetes, del Instituto Nacional del Corazón, Pulmón y Sangre, de la Asociación Americana del Corazón, de la Federación Mundial del Corazón, de la Sociedad Internacional de Aterosclerosis y de la Asociación Internacional para el Estudio de la Obesidad. Resultados: Se incluyeron 773 mujeres, 78,65% premenopaúsicas (n=608) y 21,35% post- menopáusicas (n=165). El 27,8% (n=46) de mujeres post-menopáusicas tenían SM vs. 14,6% (n=89) de las pre-menopaúsicas, con una diferencia estadísticamente significativa de p<0,0001 (Chi-cuadrado 15.7845). Conclusiones: En las mujeres post-menopáusicas se manifestó una mayor incidencia de SM cuando se compara con las pre-menopaúsicas, por lo que se incrementa el riesgo cardiovascular. Se sugiere que deberían ser tratadas en forma temprana con el fin de reducir su mortalidad.spa
dc.description.abstractIntroduction and Objectives: Menopause represents a transition in female reproductive life, which has been associated with the development of typical characteristics of metabolic syndrome (MetS). These include increased abdominal central fat, impaired lipid profile and insulin resistance. Awareness MetS and its prevalence in pre and post-menopausal women, will be useful in developing future strategies to reduce its presence and with-it cardiovascular disease. Material and methods: This was a cross-sectional study, conducted in Barranquilla, Colombia between October and November 2016, in women of working age. The diagnosis of MetS was made with at least three of the five criteria proposed by the consensus of the International Diabetes Federation, the National Heart, Lung and Blood Institute, the American Heart Association, the World Heart Federation, the International Society of Atherosclerosis and the International Association for the Study of Obesity. Results: A total of 773 women were enrolled in our study, from which 78.65% were pre-menopausal (n=608) and 21.35% post-menopausal (n=165). The presence of MetS was seen in 27.8% (n=46) of post-menopausal in comparison to 14.6 % (n=89) of the pre-menopausal women, representing a statistically significant difference (Chisquare 15.7845 p <0.0001). Conclusions: MetS has a higher prevalence in postmenopausal women when compared to pre-menopausal women. As MetS is present, cardiovascular risk increases. This population should be identified early in time in order to screen, prevent and reduce their mortality.eng
dc.language.isospaspa
dc.publisherCooperativa servicios y suministros 212518 RSspa
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista Latinoamericana de Hipertensiónspa
dc.sourceVol. 13, No. 4 (2018)spa
dc.source.urihttp://www.revhipertension.com/rlh_4_2018/15_prevalencia_sindrome_metabolico.pdfspa
dc.subjectSíndrome metabólicospa
dc.subjectPost-menopausiaspa
dc.subjectEdad laboralspa
dc.subjectMetabolic syndromeeng
dc.subjectPost-menopausaleng
dc.subjectWorking ageeng
dc.titleLa prevalencia del síndrome metabólico en mujeres postmenopáusicasspa
dc.title.alternativePrevalence of the metabolic syndrome in post-menopausal womeneng
dc.typearticlespa
dcterms.bibliographicCitationReaven G, Hoffman B. A role for insulin in the etiology and course of hypertension? Lancet. 1987; 2:435-7.eng
dcterms.bibliographicCitationGrant R, Meigs J. Should the insulin resistance syndrome be treated in the elderly? Drugs Aging. 2004; 21:141-51.eng
dcterms.bibliographicCitationLorenzo C, Williams K, Hunt K, Haffner S. The National Cholesterol Education Program- Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007; 30: 8-13.eng
dcterms.bibliographicCitationCubillos-Garzón LA, Casas JP, Morillo CA, Bautista L. Congestive heart failure in Latin America the next epidemic. Am Heart J. 2004;47(3):412-7.eng
dcterms.bibliographicCitationRoyer M, Castelo-Branco C, Blumel JE, Chedraui PA, Danckers L, Bencosme A, et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric. 2007;10(2):164-70.eng
dcterms.bibliographicCitationBustos P, da Silva AA, Amigo H, Bettiol H, Barbieri MA. Metabolic syndrome in young adults from two socioeconomic Latin American settings. Nutr Metab Cardiovasc Dis. 2007;17(8):581-9.eng
dcterms.bibliographicCitationJames WP. The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263(4):336-52.eng
dcterms.bibliographicCitationRojas S, Lopera J, Cardona J, Vargas N, Hormaza M. Síndrome metabólico en la menopausia, conceptos clave. Rev. Chil Obstet Ginecol. 2014;79(2):121-128spa
dcterms.bibliographicCitationRoss LA, Polotsky AJ. Metabolic correlates of menopause: an update. Curr Opin Obstet Gynecol. 2012; 24(6):402-7.eng
dcterms.bibliographicCitationvan der Leeuw J, Wassink AM, van der Graaf Y, Westerveld HE, Visseren FL. On behalf of the Second Manifestations of ARTerial Disease (SMART) Study Group. Age-related differences in abdominal fat distribution in premenopausal and postmenopausal women with cardiovascular disease. Menopause. 2013;20(4):409-17.eng
dcterms.bibliographicCitationEbrahimpour P, Fakhrzadeh H, Heshmat R, Ghodsi M, Bandarian F, Larijani B. Metabolic syndrome and menopause: A population-based study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2010; 4:5-9.eng
dcterms.bibliographicCitationLobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas. 2008;60(1):10-8.eng
dcterms.bibliographicCitationYoldemir T, Erenus M. The prevalence of metabolic syndrome in preand post-menopausal women attending a tertiary clinic in Turkey. Eur J Obstet Gynecol Reprod Biol. 2012; 164(2):172-5.eng
dcterms.bibliographicCitationAiny E, Mirmiran P, ZahediAsl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturitas. 2007;58(2):150-5.eng
dcterms.bibliographicCitationAmerican heart association. Heart Disease and Stroke Statistics – 2008 Update. Dallas, Tex: American Heart Association; 2008.eng
dcterms.bibliographicCitationMelgarejo E, Urdinola J. Riesgo cardiovascular de la mujer menopáusica. Ed. Sociedad Colombiana de Cardiología, FECOLSOG 2011. Ed Panamericana 2012.spa
dcterms.bibliographicCitation2018-DANE Colombia Estadisticas vitales. http://www.dane.gov.co/ index.php/poblacion-y-demografia/nacimientos-y-defunciones/118- demograficas/estadisticas-vitales/2877 defunciones-no-fetalesspa
dcterms.bibliographicCitationMolina D, Muñoz D. Síndrome metabólico en la mujer. Rev Colomb de Cardiol. 2018;25(S1):21-29spa
dcterms.bibliographicCitationSánchez F, Jaramillo N, Vanegas A, Echeverri J, León C, Echavarría E et al. Prevalencia y comportamiento de los factores de riesgo del síndrome metabólico según los diferentes intervalos de edad, en una población femenina del área de influencia de la Clínica Las Américas, en Medellín - Colombia. Rev. Col. Cardiol. 2008; 15(3): 102-110.spa
dcterms.bibliographicCitationAschner P, Chávez M, Izquierdo J, Sole J, Tarazona A, Pinzón JB, et al. Prevalence of the metabolic syndrome in a rural and urban population in Colombia. Diab Res Clin Prac 2002; 57 (Suppl 1): 532.eng
dcterms.bibliographicCitationVillegas A, Botero J, Arango I, Arias S, Toro M. Prevalencia de síndrome metabólico en El Retiro, Colombia. IATREIA 2003; 16: 291-297spa
dcterms.bibliographicCitationManzur F, De la Ossa M, Trespalacios E, Abuabara Y, Lujan M. Prevalencia del síndrome metabólico en el municipio de Arjona, Colombia. Rev Colomb Cardiol. 2008;15:215-222spa
dcterms.bibliographicCitationUrina-Jassir D, Urina-Triana M, Balaguera-Mendoza J, Montenegrorolong L, Urina Jassir M, Urina-Triana ME. Prevalencia del síndrome metabólico en hipertenso estadio I. Rev Colomb Cardiol. 2016; 23(5):365-374.eng
dcterms.bibliographicCitationAlberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, et al. Harmonizing the metabolic syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation. 2009; 120:1640-1645.eng
dcterms.bibliographicCitationAschner P, Buendía R, Brajkovich I, González A, Figueredo R, Juárez X, et al. Determination of the cut-off point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women Diabetes Res Clin Pract. 2011; 93:243-247.eng
dcterms.bibliographicCitationTabares MK, Aguilera JR, Velázquez B, Garza P, Angulo LC, García R. Síndrome metabólico en menopausia: implicaciones de la terapia hormonal. Perinatol Reprod Hum. 2012;26(1):25-9.spa
dcterms.bibliographicCitationSchmitt AC, Cardoso MR, Lopes H, Pereira WM, Pereira EC, de Rezende DA, et al. Prevalence of metabolic syndrome and associated factors in women aged 35 to 65 years who were enrolled in a family health program in Brazil. Menopause. 2013; 20(4):470-6.eng
dcterms.bibliographicCitationFigueiredo Neto JA, Figuerêdo ED, Barbosa JB, Barbosa FF, Costa GRC, Nina VJS. et al. Metabolic syndrome and menopause: Cross-sectional study in gynecology clinic. Arq Bras Cardiol. 2010;95(3):339–45. doi: 10.1590/S0066-782X2010005000094.eng
dcterms.bibliographicCitationChedraui P, San Miguel G, Villacreses D, Dominguez A, Jaramillo W, Escobar GS, et al; Research Group for the Omega Women’s Health Project. Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome. Maturitas. 2013;74(2):154-9.eng
dcterms.bibliographicCitationHidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. The metabolic syndrome among postmenopausal women in Ecuador. Gynecological Endocrinol. 2006;22(8):447–54. doi: 10.1080/09513590600890272.eng
dcterms.bibliographicCitationMesch V, Boero L, Siseles N, Royer M, Prada M, Sayegh F. et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric. 2006;9(1):40–8. doi: 10.1080/13697130500487331.eng
dcterms.bibliographicCitationAlbuquerque J, Durans E, Barbosa J, De Flores F, Cardoso G, da Silva V, et al. Síndrome Metabólico y Menopausia: Estudio Transversal en Ambulatorio de Ginecología. Arq Bras Cardiol. 2010; 95(3): 339-345.spa
dcterms.bibliographicCitationEshtiaghia R, Esteghamatib A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas. 2010;65(3):262-6.eng
dcterms.bibliographicCitationMonterrosa-Castro A, Blümel JE, Portela-Buelvas K, Mezones- Holguín E, Barón G, Bencosme A, et al; for the Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Type II diabetes mellitus and menopause: a multinational study. Climacteric. 2013;16(6):663-72.eng
dcterms.bibliographicCitationEsposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Rafaniello C, et al. Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopausia. 2013; 20(12):1301-9.eng
dcterms.bibliographicCitationRohan TE, Heo M, Choi L, Datta M, Freudenheim JL, Kamensky V, et al. Body fat and breast cancer risk in postmenopausal women: a longitudinal study. J CancerEpidemiol. 2013;2013:754815.eng
dcterms.bibliographicCitationHallajzadeh J, Khoramdad M, Izadi N, Karamzad N, Almasi A, Ayubi E et al. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. The Journal of the North American Menopause Society 2018; 25:1-10eng
dcterms.bibliographicCitationLambrinoudaki I, Kazani A, Armeni E, Rizos D, Augoulea A, Kaparos G et al. The metabolic syndrome is associated with carotid atherosclerosis and arterial stiffness in asymptomatic, nondiabetic postmenopausal women, Gynecological Endocrinology 2018; 34:78-82, DOI: 10.1080/09513590.2017.1344208eng
dcterms.bibliographicCitationVandana G, Sameeksha M, Supriya M, Sandeep K, Vani G. Association of Leptin: Adiponectin ratio and metabolic risk markers in postmenopausal women. Immunology Letters 2018; 196:63-67eng
dcterms.bibliographicCitationSteckling F, Boufleur J, da Cunha F, Lopes D, Bresciani G, Kretzmann N, et al. High-intensity interval training improves inflammatory and adipokine profiles in postmenopausal women with metabolic syndrome, Archives of Physiology and Biochemistry, 2018 DOI: 10.1080/13813455.2018.1437750eng
dcterms.bibliographicCitationAschner P, Ruiz A, Balkau B, Massien C, Haffner SM; Latin America and the Caribbean International Day for Evaluation of Abdominal Adiposity (IDEA) National Coordinators and Investigators. Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America. J Clin Hypertens (Greenwich). 2009;11(12):769-74.eng
dcterms.bibliographicCitationOrtiz R, Torres M, Bermúdez V, Michel C, Illescas M, Rodas O, et al. La circunferencia abdominal elevada: un fenotipo asociado a múltiples factores de riesgo cardiovascular. Cumbe-Ecuador.Rev Síndrome Cardiometabolico y enfermedades crónicas degenerativas 2017;7(1):50-57eng
dcterms.bibliographicCitationLobo R, Davis S, De Villiers T, Gompel A, Henderson V, Hodis H et al. Prevention of diseases after menopause, Climacteric 2014;17(5):540- 556, DOI: 10.3109/13697137.2014.933411eng
dcterms.bibliographicCitationLobo R. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;20(60):10-18eng
dcterms.bibliographicCitationPolotsky H, Polotsky A. Metabolic implications of menopause. Semin Reprod Med 2010;28(5):426-434eng
dcterms.bibliographicCitationChedraui P, Pérez-López FR, Escobar GS, Palla G, Montt-Guevara M, Cecchi E, Genazzani AR, Simoncini T, Research Group for the Omega Women’s Health Project. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas. 2014; 79(1):86-90.eng
dcterms.bibliographicCitationChedraui P, Escobar GS, Pérez-López FR, Palla G, Montt-Guevara M, Cecchi E, Genazzani AR, Simoncini T, Research Group for the Omega Women’s Health Project. Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome. Maturitas. 2014;77(4):370-4.eng
dcterms.bibliographicCitationChacín M, Rojas J, Rodríguez D, Núñez M, Márquez M, Leal N, et al. Predisposición humana a la Obesidad, Síndrome Metabólico y Diabetes: El genotipo ahorrador y la incorporación de los diabetogenes al genoma humano desde la Antropología Biológica. Diabetes Internacional. 2011;3(2):36-49spa


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem